This study aimed to examine the association between the hemoglobin glycation index (HGI) and carotid artery plaque (CAP) in patients with coronary heart disease (CHD). We conducted a cross-sectional analysis of 10,778 patients with CHD. The participants were divided into three groups by HGI tertiles (T1 HGI<−0.44, T2 −0.44 ≤ HGI ≤ 0.15, T3 HGI>0.15). The presence of CAP was used to diagnose by carotid ultrasonography. Logistic regression analysis was used to analyze the association between the HGI and CAP. The association between HGI and CAP was also assessed according to sex, age, smoking status, and drinking status. We further assessed the association between HGI and the ultrasound characteristics of CAP. The baseline analysis showed substantial differences in relevant parameters between the three groups of patients with CHD according to the tertiles of the HGI. Multivariate logistic regression analysis showed that HGI was significantly associated with CAP (odds ratio [OR] 1.32; 95% confidence interval [CI] 1.26–1.39). The association between HGI and CAP exists among different sex, age, smoking, and drinking status. Furthermore, there was a significant and positive association between HGI and all four different echogenicities of the CAP.
TsaoCWAdayAWAlmarzooqZI, et al.Heart disease and stroke statistics-2022 update: a report from the American heart association. Circulation. 2022; 145: e153-e639.
2.
WangSChenYWangR, et al.Effectiveness of red yeast rice on carotid atherosclerosis: a systematic review and meta-analysis. Front Pharmacol. 2022; 13: 937809.
3.
SillesenHSartoriSSandholtB, et al.Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. European Heart Journal - Cardiovascular Imaging. 2018; 19: 50-51042.
4.
JangCWKimYKKimKH, et al.Predictors for high-risk carotid plaque in asymptomatic Korean population. Cardiovascular therapeutics. 2020; 2020: 6617506.
5.
BosDArshiBvan den BouwhuijsenQ, et al.Atherosclerotic carotid plaque composition and incident stroke and coronary events. J Am Coll Cardiol. 2021; 77: 35-1426.
6.
Juárez-RojasJGPosadas-RomeroCMartínez-AlvaradoR, et al.Type 2 diabetes mellitus is associated with carotid artery plaques in patients with premature coronary heart disease. Rev Invest Clin. 2018; 70: 9-301.
7.
HuangESLaiteerapongNLiuJY, et al.Rates of complications and mortality in older patients with diabetes mellitus. JAMA Intern Med. 2014; 174: 8-251.
8.
CavenderMAStegPGSmithSJ, et al.Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death. Circulation. 2015; 132: 923-931.
9.
American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022; 45: S17-S38.
CohenRMSniederHLindsellCJ, et al.Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care. 2006; 29: 1739-1743.
12.
NayakAUSinghBMDunmoreSJ. Potential Clinical error arising from use of HbA1c in diabetes: effects of the glycation gap. Endocr Rev. 2019; 40: 988-999.
13.
HempeJMHsiaDS. Variation in the hemoglobin glycation index. J Diabetes Complicat. 2022; 36: 108223.
14.
LinCHLaiYCChangTJ, et al.Hemoglobin glycation index predicts renal function deterioration in patients with type 2 diabetes and a low risk of chronic kidney disease. Diabetes Res Clin Pract. 2022; 186: 109834.
15.
McCarterRJHempeJMGomezR, et al.Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care. 2004; 27: 1259-1264.
16.
KleinKRFranekEMarsoS, et al.Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE. BMJ Open Diabetes Research & Care. 2021; 9: e002339.
17.
ZhangLWangMZhangR, et al.Hemoglobin glycation index in relationship to the risk of cardiovascular complication in patients with type 2 diabetes: A systematic review and meta-analysis. J Diabetes Complicat. 2020; 34: 107673.
18.
KimWGoTKangDR, et al.Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: a 10-year longitudinal cohort study. J Diabetes Complicat. 2021; 35: 107760.
19.
AhnCHMinSHLeeDH, et al.Hemoglobin glycation index is associated with cardiovascular diseases in people with impaired glucose metabolism. J Clin Endocrinol Metabol. 2017; 102: 2905-2913.
20.
MariniMAFiorentinoTVSuccurroE, et al.Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS One. 2017; 12: e0175547.
21.
LiuYLiZWangX, et al.Effects of adjuvant Chinese patent medicine therapy on major adverse cardiovascular events in patients with coronary heart disease angina pectoris: a population-based retrospective cohort study. Acupuncture and Herbal Medicine. 2022; 2: 109-117.
22.
LiZChengQLiuY, et al.Low−/high-density lipoprotein cholesterol ratio and carotid plaques in patients with coronary heart disease: a Chinese cohort study. Lipids Health Dis. 2021; 20: 144.
23.
LiuBWangZFuJ, et al.Sensitivity to thyroid hormones and risk of prediabetes: a cross-sectional study. Front Endocrinol. 2021; 12: 657114.
24.
YangTLiuYLiL, et al.Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China. Cardiovasc Diabetol. 2022; 21: 93.
25.
LiuYZhuYJiaW, et al.Association between lipid profiles and presence of carotid plaque. Sci Rep. 2019; 9: 18011.
26.
EdwardJAJoseyKBahnG, et al.Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis. Cardiovasc Diabetol. 2022; 21: 58.
27.
Echouffo-TcheuguiJBChenHKalyaniRR, et al.Glycemic markers and subclinical cardiovascular disease: the Jackson heart study. Circulation. Cardiovascular imaging. 2019; 12: e008641.
28.
SunBZhaoHLiuX, et al.Elevated hemoglobin A1c is associated with carotid plaque vulnerability: novel findings from magnetic resonance imaging study in hypertensive stroke patients. Sci Rep. 2016; 6: 33246.
29.
XuRZhangTWanY, et al.Prospective study of hemoglobin A1c and incident carotid artery plaque in Chinese adults without diabetes. Cardiovasc Diabetol. 2019; 18: 153.
30.
ToschiEMichalsAAdamA, et al.Usefulness of CGM-derived metric, the glucose management indicator, to assess glycemic control in non-white individuals with diabetes. Diabetes Care. 2021; 44: 2787-2789.
31.
GersteinHCGersteinMEMillerRP, et al.Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358:59-2545.
32.
CampbellLPepperTShipmanK. HbA1c: a review of non-glycaemic variables. J Clin Pathol. 2018; 72: 12-19.
33.
SodiRMcKayKDampetlaS, et al.Monitoring glycaemic control in patients with diabetes mellitus. BMJ. 2018; 363: k4723.
34.
HempeJMGomezRMcCarterRJ, et al.High and low hemoglobin glycation phenotypes in type 1 diabetes. J Diabetes Complicat. 2002; 16: 313-320.
35.
HsiaDSRasouliNPittasAG, et al.Implications of the hemoglobin glycation index on the diagnosis of prediabetes and diabetes. J Clin Endocrinol Metabol. 2020; 105: e130-e138.
36.
JinJLSunDCaoYX, et al.Triglyceride glucose and haemoglobin glycation index for predicting outcomes in diabetes patients with new-onset, stable coronary artery disease: a nested case-control study. Ann Med. 2018; 50: 576-586.
37.
KimMKJeongJSYunJS, et al.Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: a 10-year longitudinal cohort study. J Diabetes Complicat. 2018; 32: 906-910.
38.
XuSQinZYuanR, et al.The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus. Frontiers in Cardiovascular Medicine. 2022; 9: 992252.
39.
RheeEJChoJHKwonH, et al.Association between coronary artery calcification and the hemoglobin glycation index: the Kangbuk Samsung health study. J Clin Endocrinol Metabol. 2017; 102: 4634-4641.
40.
FelipeDLHempeJMLiuS, et al.Skin intrinsic fluorescence is associated with hemoglobin a1c and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes. Diabetes Care. 2011; 34: 1816-1820.
41.
ArivazhaganLLópez-DíezRShekhtmanA, et al.Glycation and a spark of ALEs (Advanced Lipoxidation End Products) - Igniting RAGE/Diaphanous-1 and cardiometabolic disease. Frontiers in Cardiovascular Medicine. 2022; 9: 937071.
42.
Twarda-ClapaAOlczakABiałkowskaAM, et al.Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022; 11: 1312.
43.
WoodwardHJZhuDHadokeP, et al.Regulatory role of sex hormones in cardiovascular calcification. Int J Mol Sci. 2021; 22: 4620.
44.
TeohJPLiXSimonciniT, et al.Estrogen-mediated gaseous signaling molecules in cardiovascular disease. Trends Endocrinol Metabol. 2020; 31: 773-784.
45.
QinWGuoJGouW, et al.Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: what we know and where we go. Chinese Herbal Medicines. 2022; 14: 234-243.
46.
VisserenFMachFSmuldersYM, et al.2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42: 3227-3337.
47.
YangYPengNChenG, et al.Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events. Cardiovasc Diabetol. 2022; 21: 14.
48.
MatsumotoCMiedemaMDOfmanP, et al.An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease. J Cardpulm Rehabil Prev. 2014; 34: 159-171.
49.
MillwoodIYWaltersRGMeiXW, et al.Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet. 2019; 393: 1831-1842.
50.
RosoffDBDavey SmithSGMehtaN, et al.Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study. PLoS Med. 2020; 17: e1003410.
51.
Kamtchum-TatueneJNoubiapJJWilmanAH, et al.Prevalence of High-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis. JAMA Neurol. 2020; 77: 35-1524.
52.
GrønholdtMLWiebeBMLaursenH, et al.Lipid-rich carotid artery plaques appear echolucent on ultrasound B-mode images and may be associated with intraplaque haemorrhage. Eur J Vasc Endovasc Surg. 1997; 14: 45-439.
53.
GroganJKShaalanWEChengH, et al.B-mode ultrasonographic characterization of carotid atherosclerotic plaques in symptomatic and asymptomatic patients. J Vasc Surg. 2005; 42: 435-441.
54.
PatouliasDStavropoulosKImprialosK, et al.Inflammatory markers in cardiovascular disease; lessons learned and future perspectives. Curr Vasc Pharmacol. 2021; 19: 42-323.
55.
SchnabelRBYinXLarsonMG, et al.Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol. 2013; 33: 1728-1733.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
